Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 109651-109700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03409263
Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts
N/A
Recruiting
400 participants
Started: Mar 28, 2018 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT02941107
Optimising Rotavirus Vaccine in Aboriginal Children
PHASE4
Active, not recruiting
1,000 participants
Started: Mar 27, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03418818
FAZA PET/MRI Sarcoma
NA
Recruiting
50 participants
Started: Mar 27, 2018 · Completed: Oct 31, 2028
1 condition
1 sponsor
1 location
NCT03003572
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
N/A
Recruiting
185 participants
Started: Mar 27, 2018 · Completed: Jun 30, 2027
1 condition
2 sponsors
8 locations
NCT03403465
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
PHASE2
Active, not recruiting
90 participants
Started: Mar 27, 2018 · Completed: Apr 5, 2028
4 conditions
1 sponsor
1 location
NCT03310528
Gastric Ultrasound for Estimation of the Aspiration Risk Study
N/A
Active, not recruiting
200 participants
Started: Mar 27, 2018 · Completed: Jul 14, 2026
1 condition
1 sponsor
1 location
NCT03494660
SCP Hip Outcomes Study
N/A
Active, not recruiting
82 participants
Started: Mar 27, 2018 · Completed: Dec 31, 2025
7 conditions
1 sponsor
6 locations
NCT03417739
A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
PHASE2
Active, not recruiting
13 participants
Started: Mar 26, 2018 · Completed: Aug 31, 2025
1 condition
2 sponsors
2 locations
NCT03223961
A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS
PHASE3
Active, not recruiting
124 participants
Started: Mar 26, 2018 · Completed: Oct 1, 2028
1 condition
1 sponsor
39 locations
NCT03689049
SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients
NA
Enrolling by invitation
104 participants
Started: Mar 26, 2018 · Completed: Mar 31, 2027
6 conditions
18 sponsors
9 locations
NCT03458260
Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
PHASE2
Active, not recruiting
74 participants
Started: Mar 26, 2018 · Completed: Mar 31, 2025
1 condition
1 sponsor
22 locations
NCT03439267
Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events
NA
Active, not recruiting
5,765 participants
Started: Mar 26, 2018 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT03349801
Development of Novel Clinical Endpoints in Intermediate AMD
N/A
Active, not recruiting
718 participants
Started: Mar 26, 2018 · Completed: Feb 28, 2026
1 condition
14 sponsors
20 locations
NCT03439683
KAP Asynchrony Survey
N/A
Recruiting
300 participants
Started: Mar 26, 2018 · Completed: Dec 1, 2024
4 conditions
1 sponsor
1 location
NCT03162653
Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
PHASE3
Recruiting
760 participants
Started: Mar 25, 2018 · Completed: Jan 31, 2026
2 conditions
15 sponsors
12 locations
NCT03473821
Motor Imagery to Facilitate Sensorimotor Relearning After ACL Injury
NA
Active, not recruiting
106 participants
Started: Mar 25, 2018 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT03297606
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
PHASE2
Recruiting
720 participants
Started: Mar 23, 2018 · Completed: Jan 31, 2027
3 conditions
6 sponsors
10 locations
NCT03517761
Use of Bone Marrow Concentrate for Treatment of Alar, Accessory, and Transverse Ligament Injuries
NA
Recruiting
80 participants
Started: Mar 23, 2018 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT03461120
Improving Postamputation Functioning by Decreasing Phantom Pain With Perioperative Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study
PHASE4
Active, not recruiting
203 participants
Started: Mar 23, 2018 · Completed: Nov 18, 2026
2 conditions
10 sponsors
8 locations
NCT03390504
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
PHASE3
Active, not recruiting
629 participants
Started: Mar 23, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
345 locations
NCT03795246
Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer
NA
Active, not recruiting
132 participants
Started: Mar 23, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT05663489
Neurobiological Markers of Treatment Response for Anxiety and OCD
N/A
Recruiting
500 participants
Started: Mar 23, 2018 · Completed: Dec 11, 2027
3 conditions
7 sponsors
1 location
NCT03246529
A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)
PHASE3
Active, not recruiting
180 participants
Started: Mar 23, 2018 · Completed: Sep 30, 2029
1 condition
1 sponsor
18 locations
NCT03446157
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
24 participants
Started: Mar 23, 2018 · Completed: Jan 26, 2026
5 conditions
3 sponsors
1 location
NCT03418038
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
PHASE2
Recruiting
80 participants
Started: Mar 23, 2018 · Completed: Mar 31, 2026
8 conditions
2 sponsors
4 locations
NCT03395210
A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)
PHASE2
Active, not recruiting
81 participants
Started: Mar 22, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
31 locations
NCT03318406
Post-Market BTVA Registry
N/A
Recruiting
300 participants
Started: Mar 22, 2018 · Completed: Dec 1, 2030
1 condition
1 sponsor
20 locations
NCT03457493
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
PHASE1/PHASE2
Recruiting
205 participants
Started: Mar 22, 2018 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT03479268
Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
PHASE1
Active, not recruiting
18 participants
Started: Mar 22, 2018 · Completed: Nov 6, 2025
18 conditions
2 sponsors
2 locations
NCT03440450
A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer
PHASE1
Active, not recruiting
90 participants
Started: Mar 22, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
7 locations
NCT04733274
Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing
N/A
Active, not recruiting
227 participants
Started: Mar 22, 2018 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT03486821
Ultra-hypofractionated Radiation in Prostate Cancer
NA
Active, not recruiting
13 participants
Started: Mar 22, 2018 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT03412396
Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy
PHASE2
Active, not recruiting
45 participants
Started: Mar 22, 2018 · Completed: Mar 30, 2026
2 conditions
2 sponsors
1 location
NCT03485430
Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up
NA
Active, not recruiting
140 participants
Started: Mar 22, 2018 · Completed: Dec 30, 2025
5 conditions
4 sponsors
3 locations
NCT06687629
Best Practice in the Management of Concha Bullosa in FESS Operation
NA
Active, not recruiting
62 participants
Started: Mar 21, 2018 · Completed: Dec 31, 2025
7 conditions
1 sponsor
1 location
NCT03511846
Pain Biomarker Study
PHASE1
Enrolling by invitation
371 participants
Started: Mar 21, 2018 · Completed: May 31, 2026
7 conditions
2 sponsors
1 location
NCT03345823
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
PHASE3
Active, not recruiting
747 participants
Started: Mar 21, 2018 · Completed: Sep 30, 2027
1 condition
1 sponsor
466 locations
NCT03499587
Effects of Maternal Obesity on Offspring Brain Development
N/A
Active, not recruiting
13 participants
Started: Mar 21, 2018 · Completed: Dec 27, 2026
1 condition
1 sponsor
1 location
NCT03477500
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)
PHASE3
Active, not recruiting
100 participants
Started: Mar 21, 2018 · Completed: Mar 21, 2028
1 condition
1 sponsor
8 locations
NCT03883269
Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients
PHASE4
Recruiting
30 participants
Started: Mar 20, 2018 · Completed: Dec 31, 2019
1 condition
2 sponsors
1 location
NCT03484884
A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
N/A
Active, not recruiting
102 participants
Started: Mar 20, 2018 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT03598361
Mineral Status in Pregnant Women
N/A
Recruiting
550 participants
Started: Mar 20, 2018 · Completed: Jul 30, 2025
1 condition
1 sponsor
1 location
NCT03383419
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
PHASE2
Active, not recruiting
15 participants
Started: Mar 20, 2018 · Completed: Dec 30, 2025
1 condition
1 sponsor
3 locations
NCT03406338
Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease
PHASE4
Active, not recruiting
60 participants
Started: Mar 20, 2018 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT05414396
Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities
NA
Active, not recruiting
347 participants
Started: Mar 20, 2018 · Completed: Oct 27, 2025
2 conditions
2 sponsors
1 location
NCT03280862
DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS
NA
Active, not recruiting
1,000 participants
Started: Mar 20, 2018 · Completed: Jun 30, 2026
2 conditions
5 sponsors
5 locations
NCT03906669
A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.
PHASE2
Recruiting
200 participants
Started: Mar 20, 2018 · Completed: Apr 30, 2024
2 conditions
1 sponsor
1 location
NCT03456843
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer
PHASE2
Recruiting
190 participants
Started: Mar 20, 2018 · Completed: Mar 31, 2027
1 condition
2 sponsors
17 locations
NCT03436485
Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
PHASE1/PHASE2
Active, not recruiting
204 participants
Started: Mar 19, 2018 · Completed: Jul 31, 2026
1 condition
1 sponsor
20 locations
NCT03467386
Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia
PHASE1
Recruiting
18 participants
Started: Mar 19, 2018 · Completed: Apr 6, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
2191
2192
2193
2194
2195
2196
2197
More pages
2369
Next